🔎 Trials Near Me

Akèy › Twoub depresif majè › Pennsylvania › Philadelphia

Etid klinik pou Twoub depresif majè nan Philadelphia, PA

23 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Philadelphia, Philadelphia
  • Flourish Research Philadelphia, Philadelphia
Laj 18 a 85 · Tout sèks · Mizajou Oct 5, 2026 · NCT06793397

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Ap rekriteFaz 3
  • Adams Clinical Philadelphia, Philadelphia
Laj 18 a 74 · Tout sèks · Mizajou Oct 5, 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07412756

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Philadelphia, Philadelphia
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

Precision Depression Adalimumab Trial

Ap rekriteFaz 2
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07845604

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • University of Pennsylvania - Perelman School of Medicine, Philadelphia
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • University of Pennsylvania, Philadelphia
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

Ap rekriteFaz 1 bonè
  • University of Pennsylvania, Philadelphia
Laj 25 a 65 · Tout sèks · Mizajou Sep 10, 2026 · NCT06788249

Decoding and Modulating Affective Brain States

Ap rekriteMande peman pou patisipan yo
  • University of Pennsylvania, Philadelphia
Laj 18 a 65 · Tout sèks · Mizajou Sep 3, 2026 · NCT05437705

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Media · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • Pennsylvania Hospital, Philadelphia
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Media · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

Ap rekriteFaz 3
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07226232

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical - Philadelphia, Philadelphia
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Adams Clinical, Philadelphia
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07196501

Triage Survey for Psychiatry Research Eligibility

Ap rekriteEtid obsèvasyon
  • Adams Clinical, Philadelphia, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • University of Pennsylvania, Philadelphia
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Taking Action for College Students

Ap rekrite
  • Temple University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT06700902

Neurofeedback to Treat Depression - 2

Ap rekrite
  • Center for Neuromodulation in Depression and Stress, Philadelphia
Laj 18 a 65 · Tout sèks · Mizajou Dec 4, 2025 · NCT07159061

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 350, Media · 12 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.